With more clinical data available than ever before, it’s evident that there are significant limitations to the current gene therapy vectors in play.
Drug developers are desperate for more targeted, specific, and safe vectors to plug into their pipelines, and they are looking to partner with organizations who can solve their vector challenges, from synthesising genes to manufacturing next-generation capsids.
Partnering with us provides a unique platform to showcase how your services meet the needs of this specific audience who work within vector design and innovation, and ultimately want to develop and manufacture high quality and safe gene therapy vectors.
We have a limited number of partnership opportunities available, including virtual speaking positions across our agenda. The meeting will unite 80+ vector engineering, design & innovation specialists to engage with, so if you’re looking to showcase your expertise, demonstrate thought leadership, or generate leads to build new relationships with the industry, we can help build a bespoke partnership to support your business development objectives.
Email us at firstname.lastname@example.org for more information about the digital partnership opportunities available which will deliver on your 2021 commercial aims. Act now to stay ahead of the curve and seize the wealth of opportunity on offer.